Explore how pharma teams, researchers, and CROs use Hyfe CMS to advance cough science, build stronger trials, and bring more effective therapies to patients.
Audience
Indication / Therapeutic Area
Hyfe's CoughMonitor Suite captured continuous, objective cough data on standalone wrist-worn watches, with no study phone or mobile network required during each monitoring window, at a fraction of the setup and staff burden of the team's other digital health tools.
21 Aug 2026
Hyfe's cough tracking provided continuous, objective cough measurement alongside high-resolution oesophageal manometry, supporting a multi-endpoint design that examined cough and oesophageal function together for the first time.
02 Aug 2026
Across 565 participants in five countries, objective cough monitoring showed that TB cough falls within the first days of treatment, distinct from other respiratory disease, establishing continuous cough frequency as a fast, decentralized readout of TB treatment response.
30 Jul 2026
Hyfe's CoughMonitor Suite delivered objective cough data that demonstrated a measurable reduction in cough frequency across 12,000+ hours of continuous monitoring and 97.9% median adherence, giving Climatic Health the quantitative evidence their investors and scientific advisors needed to move forward.
26 May 2026
